University of Oklahoma/Sarah Cannon Research Institute — Oklahoma City, Oklahoma

University of Oklahoma/Sarah Cannon Research Institute is a clinical research site located in Oklahoma City, Oklahoma, United States 73104.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

University of Oklahoma/Sarah Cannon Research Institute has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer.

Sponsors: Artios Pharma Ltd.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Oklahoma/Sarah Cannon Research Institute?

University of Oklahoma/Sarah Cannon Research Institute has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Oklahoma/Sarah Cannon Research Institute conducted?

University of Oklahoma/Sarah Cannon Research Institute has 1 clinical trials on record. Their work covers Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer.

Is University of Oklahoma/Sarah Cannon Research Institute accredited by Crixeo Health?

University of Oklahoma/Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Oklahoma/Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.